RESUMEN
In obese adipose tissue (AT), hypertrophic expansion of adipocytes is not matched by new vessel formation, leading to AT hypoxia. As a result, hypoxia inducible factor-1⺠(HIF-1âº) accumulates in adipocytes inducing a transcriptional program that upregulates profibrotic genes and biosynthetic enzymes such as lysyl oxidase (LOX) synthesis. This excess synthesis and crosslinking of extracellular matrix (ECM) components cause AT fibrosis. Although fibrosis is a hallmark of obese AT, the role of fibroblasts, cells known to regulate fibrosis in other fibrosis-prone tissues, is not well studied. Here we have developed an in vitro model of AT to study adipocyte-fibroblast crosstalk in a hypoxic environment. Further, this in vitro model was used to investigate the effect of hypoxia on adipocyte mechanical properties via ras homolog gene family member A (RhoA)/Rho-associated coiled-coil kinases (ROCK) signaling pathways. We confirmed that hypoxia creates a diseased phenotype by inhibiting adipocyte maturation and inducing actin stress fiber formation facilitated by myocardin-related transcription factor A (MRTF-A/MKL1) nuclear translocation. This work presents new potential therapeutic targets for obesity by improving adipocyte maturation and limiting mechanical stress in obese AT.
Asunto(s)
Adipocitos/patología , Fibroblastos/patología , Fibrosis/patología , Hipoxia/fisiopatología , Células Madre Mesenquimatosas/patología , Obesidad/patología , Fibras de Estrés/patología , Adipocitos/metabolismo , Fibroblastos/metabolismo , Fibrosis/metabolismo , Humanos , Células Madre Mesenquimatosas/metabolismo , Obesidad/metabolismo , Proteína-Lisina 6-Oxidasa/metabolismo , Fibras de Estrés/metabolismo , Transactivadores/metabolismo , Proteína de Unión al GTP rhoA/metabolismoRESUMEN
INTRODUCTION: Adipose derived stem cells (ASCs) hold great promise for clinical applications such as soft tissue regeneration and for in vitro tissue models and are notably easy to derive in large numbers. Specifically, ASCs provide an advantage for in vitro models of adipose tissue, where they can be employed as tissue specific cells and for patient specific models. However, ASC in vitro expansion may unintentionally reduce adipogenic capacity due to the stiffness of tissue culture plastic (TCPS). METHODS: Here, we expanded freshly isolated ASCs on soft and stiff substrates for 4 passages before adipogenic differentiation. At the last passage we swapped the substrate from stiff to soft, or soft to stiff to determine if short term exposure to a different substrate altered adipogenic capacity. RESULTS: Expansion on stiff substrates reduced adipogenic capacity by 50% which was not rescued by swapping to a soft substrate for the last passage. Stiff substrates had greater nuclear area and gene expression of nesprin-2, a protein that mediates the tension of the nuclear envelope by tethering it to the actin cytoskeleton. Upon swapping to a soft substrate, the nuclear area was reduced but nesprin-2 levels did not fully recover, which differentially regulated cell commitment transcriptional factors. CONCLUSION: Therefore, in vitro expansion on stiff substrates must be carefully considered when the end-goal of the expansion is for adipose tissue or soft tissue applications.
RESUMEN
Central to the development of adipose tissue (AT) engineered models is the supporting vasculature. It is a key part of AT function and long-term maintenance, but the crosstalk between adipocytes and endothelial cells is not well understood. Here, we directly co-culture the two cell types at varying ratios in a 3D Type I collagen gel. Constructs were evaluated for adipocyte maturation and function and vascular network organization. Further, these constructs were treated with forskolin, a beta-adrenergic agonist, to stimulate lipolysis and browning. Adipocytes in co-cultures were found to be less mature than an adipocyte-only control, shown by smaller lipid droplets and downregulation of key adipocyte-related genes. The most extensive vascular network formation was found in the 1:1 co-culture, supported by vascular endothelial growth factor (VEGF) upregulation. After forskolin treatment, the presence of endothelial cells was shown to upregulate PPAR coactivator 1 alpha (PGC-1α) and leptin, but not uncoupling protein 1 (UCP1), suggesting a specific crosstalk that enhances early stages of browning.
Asunto(s)
Adipocitos/citología , Tejido Adiposo Pardo/citología , Tejido Adiposo Blanco/citología , Células Endoteliales de la Vena Umbilical Humana/citología , Ingeniería de Tejidos/métodos , Técnicas de Cocultivo , Colforsina/farmacología , Colágeno Tipo I/metabolismo , Dimetilpolisiloxanos/química , Humanos , Hidrogeles/química , Leptina/metabolismo , Lipólisis , Células Madre Mesenquimatosas/citología , Microscopía Confocal , Coactivador 1-alfa del Receptor Activado por Proliferadores de Peroxisomas gamma/metabolismo , Proteína Desacopladora 1/metabolismo , Factor A de Crecimiento Endotelial Vascular/metabolismoRESUMEN
Adipose tissue (AT) has a dynamic extracellular matrix (ECM) surrounding adipocytes that allows for remodeling during metabolic fluctuations. During the progression of obesity, AT has increased ECM deposition, stiffening, and remodeling, resulting in a pro-fibrotic dysfunctional state. Here, the incorporation of ethylene glycol-bis-succinic acid N-hydroxysuccinimide ester (PEGDS) allows for control over 3D collagen hydrogel stiffness and architecture to investigate its influence on adipocyte metabolic and fibrotic function. Upon stiffening and altering ECM architecture, adipocytes did not alter their expression of key adipokines, leptin, and adiponectin. However, they do increase actin cytoskeletal fiber formation, pro-fibrotic gene expression, ECM deposition, and remodeling within a stiffer, 3D collagen hydrogel. For example, COL6A3 gene expression is upregulated approximately twofold, resulting in increased deposition of pericellular collagen VI alpha 3 surrounding adipocytes. Furthermore, inhibition of actin contractility results in a reversal of pro-fibrotic gene expression and ECM deposition, indicating that adipocytes are mediating mechanical cues through actin cytoskeletal networks. This study demonstrates that ECM stiffness and architecture plays a critical regulatory role in adipocyte fibrotic function and contributes to the overall pro-fibrotic dysfunctional state of AT during the progression of obesity and AT fibrosis.
Asunto(s)
Adipocitos/metabolismo , Tejido Adiposo/metabolismo , Colágeno Tipo VI/química , Regulación de la Expresión Génica , Hidrogeles/química , Ingeniería de Tejidos , Adipoquinas/biosíntesis , Colágeno Tipo VI/biosíntesis , Fibrosis , HumanosRESUMEN
BACKGROUND: Sustained release of local anesthetics is frequently associated with myotoxicity. The authors investigated the role of particulate delivery systems and of the pattern of drug release in causing myotoxicity. METHODS: Rats were given sciatic nerve blocks with bupivacaine solutions, two types of bupivacaine-containing microparticles (polymeric microspheres and lipid-protein-sugar particles), or blank particles with or without bupivacaine in the carrier fluid. Myotoxicity was scored in histologic sections of the injection sites. Bupivacaine release kinetics from the particles were measured. Myotoxicity of a range of bupivacaine concentrations from exposures up to 3 weeks was assessed in C2C12 myotubes, with or without microparticles. RESULTS: Both types of bupivacaine-loaded microparticles, but not blank particles, were associated with myotoxicity. Whereas 0.5% bupivacaine solution caused little myotoxicity, a concentration of bupivacaine that mimicked the amount of bupivacaine released initially from particles caused myotoxicity. Local anesthetics showed both concentration and time-dependent myotoxicity in C2C12s. Importantly, even very low concentrations that were nontoxic over brief exposures became highly toxic after days or weeks of exposure. The presence of particles did not increase bupivacaine myotoxicity in vitro but did in vivo. Findings applied to both particle types. CONCLUSIONS: Whereas the release vehicles themselves were not myotoxic, both burst and extended release of bupivacaine were. A possible implication of the latter finding is that myotoxicity is an inevitable concomitant of sustained release of local anesthetics. Particles, and perhaps other vehicles, may enhance local toxicity through indirect mechanisms.
Asunto(s)
Bupivacaína/química , Preparaciones de Acción Retardada/química , Micotoxinas/aislamiento & purificación , Bloqueo Nervioso/métodos , Nervio Ciático/patología , Anestésicos Locales/química , Animales , Células Cultivadas , Masculino , Ratones , Mioblastos/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Nervio Ciático/efectos de los fármacosRESUMEN
RATIONALE: Nitric oxide-independent agonists of soluble guanylate cyclase (sGC) have been developed. OBJECTIVES: We tested whether inhalation of novel dry-powder microparticle formulations containing sGC stimulators (BAY 41-2272, BAY 41-8543) or an sGC activator (BAY 58-2667) would produce selective pulmonary vasodilation in lambs with acute pulmonary hypertension. We also evaluated the combined administration of BAY 41-8543 microparticles and inhaled nitric oxide (iNO). Finally, we examined whether inhaling BAY 58-2667 microparticles would produce pulmonary vasodilation when the response to iNO is impaired. METHODS: In awake, spontaneously breathing lambs instrumented with vascular catheters and a tracheostomy tube, U-46619 was infused intravenously to increase mean pulmonary arterial pressure to 35 mm Hg. MEASUREMENTS AND MAIN RESULTS: Inhalation of microparticles composed of either BAY 41-2272, BAY 41-8543, or BAY 58-2667 and excipients (dipalmitoylphosphatidylcholine, albumin, lactose) produced dose-dependent pulmonary vasodilation and increased transpulmonary cGMP release without significant effect on mean arterial pressure. Inhalation of microparticles containing BAY 41-8543 or BAY 58-2667 increased systemic arterial oxygenation. The magnitude and duration of pulmonary vasodilation induced by iNO were augmented after inhaling BAY 41-8543 microparticles. Intravenous administration of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ), which oxidizes the prosthetic heme group of sGC, markedly reduced the pulmonary vasodilator effect of iNO. In contrast, pulmonary vasodilation and transpulmonary cGMP release induced by inhaling BAY 58-2667 microparticles were greatly enhanced after treatment with ODQ. CONCLUSIONS: Inhalation of microparticles containing agonists of sGC may provide an effective novel treatment for patients with pulmonary hypertension, particularly when responsiveness to iNO is impaired by oxidation of sGC.
Asunto(s)
Benzoatos/administración & dosificación , Morfolinas/administración & dosificación , Circulación Pulmonar/efectos de los fármacos , Pirazoles/administración & dosificación , Piridinas/administración & dosificación , Pirimidinas/administración & dosificación , Receptores Citoplasmáticos y Nucleares/agonistas , Vasodilatación , Administración por Inhalación , Aerosoles , Animales , Benzoatos/farmacología , GMP Cíclico/metabolismo , Relación Dosis-Respuesta a Droga , Combinación de Medicamentos , Guanilato Ciclasa , Inyecciones Intravenosas , Pulmón/efectos de los fármacos , Pulmón/metabolismo , Morfolinas/farmacología , Óxido Nítrico/administración & dosificación , Óxido Nítrico/farmacología , Oxadiazoles/administración & dosificación , Oxadiazoles/farmacología , Tamaño de la Partícula , Inhibidores de Fosfodiesterasa/administración & dosificación , Inhibidores de Fosfodiesterasa/farmacología , Polvos , Purinonas/administración & dosificación , Purinonas/farmacología , Pirazoles/farmacología , Piridinas/farmacología , Pirimidinas/farmacología , Quinoxalinas/administración & dosificación , Quinoxalinas/farmacología , Ovinos , Guanilil Ciclasa Soluble , Vasodilatación/efectos de los fármacosRESUMEN
Postoperative peritoneal adhesions can have serious, potentially lethal consequences. Pharmacotherapy and barrier devices can reduce adhesion formation to varying degrees, but their efficacy is limited by rapid clearance from the peritoneum and lack of biological activity, respectively. To overcome these limitations, we have delivered tissue-type plasminogen activator (tPA), which is deficient in the first 2-3 postoperative days, using a highly cross-linked in situ forming hyaluronan gel (HAX(hx)). We demonstrated this formulation's anti-adhesion activity in a rigorous animal model that involved recurrent adhesions. While non-treated or saline-treated animals developed widespread adhesions (frequency, both 100%; median adhesion area, 12.7 and 15.4 cm(2), respectively), tPA delivered by HAX(hx) (tPA-HAX(hx)) was highly effective in preventing recurrent adhesions (frequency, 44%; median adhesion area, 0.1cm(2)). HAX(hx) itself, tPA solution, and inactivated tPA in HAX(hx) did not provide comparable anti-adhesion activity. tPA-HAX(hx) is a system that is easy to use and potentially promising for adhesion prevention.
Asunto(s)
Materiales Biocompatibles/farmacología , Ácido Hialurónico/farmacología , Enfermedades Peritoneales/prevención & control , Activador de Tejido Plasminógeno/farmacología , Animales , Materiales Biocompatibles/química , Materiales Biocompatibles/uso terapéutico , Femenino , Geles , Ácido Hialurónico/química , Ácido Hialurónico/uso terapéutico , Modelos Animales , Enfermedades Peritoneales/etiología , Peritoneo/efectos de los fármacos , Peritoneo/patología , Complicaciones Posoperatorias/prevención & control , Conejos , Activador de Tejido Plasminógeno/química , Activador de Tejido Plasminógeno/uso terapéutico , Cicatrización de Heridas/efectos de los fármacosRESUMEN
Peritoneal adhesions are serious sequelae of surgery, and can cause significant morbidity and/or mortality due to pain, infertility, and bowel obstruction. We have designed and synthesized novel dextran (DX)-based injectable hydrogels for adhesion prevention, which are formed by mixing hydrazide-modified carboxymethyldextran (CMDX-ADH) with aldehyde-modified DX (DX-CHO) or carboxymethylcellulose (CMC-CHO). At high polymer concentrations, hydrogels formed very quickly upon mixing, e.g. 5% CMDX-ADH with 6% DX-CHO (=CMDX-DX; 1.8 s) and 5% CMDX-ADH with 6% CMC-CHO (=CMDX-CMC; 5.8 s). CMDX-DX shrank after gelling, while CMDX-CMC swelled. CMDX-ADH and CMC-CHO showed minimal to mild cytotoxicity to mesothelial cells and macrophages in vitro, while DX-CHO was very cytotoxic. However, all cross-linked gels had very mild cytotoxicity. When applied in a rabbit sidewall defect-bowel abrasion model of adhesion formation, CMDX-CMC greatly reduced the formation of adhesions while CMDX-DX worsened them.
Asunto(s)
Materiales Biocompatibles/administración & dosificación , Hidrogeles/administración & dosificación , Enfermedades Peritoneales/prevención & control , Adherencias Tisulares/prevención & control , Animales , Materiales Biocompatibles/química , Línea Celular , Línea Celular Tumoral , Reactivos de Enlaces Cruzados/química , Dextranos/química , Modelos Animales de Enfermedad , Femenino , Humanos , Hidrogeles/química , Inyecciones Intraperitoneales , Macrófagos/efectos de los fármacos , Mesotelioma/patología , Ratones , Enfermedades Peritoneales/patología , Complicaciones Posoperatorias , Conejos , Adherencias Tisulares/etiología , Adherencias Tisulares/patologíaRESUMEN
Postoperative peritoneal adhesions cause pelvic pain, infertility, and potentially lethal bowel obstruction. We have designed and synthesized an injectable hydrogel composed of cross-linkable modified hyaluronic acids (HAs) conjugated to dexamethasone (HAX-DEX), and investigated its anti-inflammatory function. HAX-DEX formed a hydrogel in <1min by cross-linking reactions between aldehyde groups and hydrazide groups. The hydrogel degraded in media over 5 days, releasing dexamethasone slowly over that time, reducing TNF-alpha and IL-6 production from lipopolysaccharide-stimulated primary mouse macrophages in vitro. HAX-DEX was biocompatible on subcutaneous injection, and caused less inflammation than unmodified cross-linked HA.
Asunto(s)
Citocinas/inmunología , Dexametasona/administración & dosificación , Portadores de Fármacos/química , Ácido Hialurónico/química , Inflamación/tratamiento farmacológico , Inflamación/inmunología , Macrófagos/inmunología , Animales , Antiinflamatorios/administración & dosificación , Antiinflamatorios/química , Células Cultivadas , Reactivos de Enlaces Cruzados/química , Dexametasona/química , Difusión , Portadores de Fármacos/administración & dosificación , Ácido Hialurónico/administración & dosificación , Hidrogeles/administración & dosificación , Hidrogeles/química , Macrófagos/efectos de los fármacos , Masculino , Ensayo de Materiales , Ratones , Resultado del TratamientoRESUMEN
Post-operative peritoneal adhesions can cause pelvic pain, infertility, and potentially lethal bowel obstruction. We have designed and synthesized injectable hydrogels that are formed by mixing hydrazide-modified hyaluronic acid (HA) with aldehyde-modified versions of cellulose derivatives such as carboxymethylcellulose (CMC), hydroxypropylmethylcellulose (HPMC), and methylcellulose (MC). Gelation of these hydrogels occurred in less than 1 min, and had higher shear moduli than that of HA-HA gel (HAX). Hydrogels degraded in the presence of hyaluronidase in vitro, with HA-MC and HA-HPMC degrading more slowly than HAX and HA-CMC. The aldehyde-modified cellulose derivatives showed dose-dependent mild-to-moderate cytotoxicity to mesothelial cells and macrophages in vitro, but all were biocompatible in the murine peritoneum, causing no adhesions for 3 weeks. All the cellulose-derived gels showed efficacy in reducing the area of adhesion formation in a rabbit sidewall defect-bowel abrasion model.
Asunto(s)
Celulosa/química , Ácido Hialurónico/química , Hidrogeles/química , Enfermedades Peritoneales/patología , Enfermedades Peritoneales/prevención & control , Peritoneo/efectos de los fármacos , Peritoneo/patología , Animales , Materiales Biocompatibles/efectos adversos , Materiales Biocompatibles/química , Celulosa/efectos adversos , Reactivos de Enlaces Cruzados/química , Ácido Hialurónico/efectos adversos , Hidrogeles/efectos adversos , Ensayo de Materiales , Ratones , Enfermedades Peritoneales/inducido químicamente , Conejos , Adherencias Tisulares/inducido químicamente , Adherencias Tisulares/patologíaRESUMEN
We studied the efficacy of an in situ cross-linked hyaluronic acid hydrogel (HAX) in preventing post-surgical peritoneal adhesions, using a rabbit sidewall defect-cecum abrasion model. Two cross-linkable precursors were prepared by modifying hyaluronic acid with adipic dihydrazide and aldehyde, respectively. The hydrogel precursors cross-linked to form a flexible hydrogel upon mixing. The hydrogel was biodegradable and provided a durable physical barrier, which was highly effective in reducing the formation of post-operative adhesions. Ten out of 12 animals in the untreated control group developed fibrous adhesions requiring sharp dissection, while only 2 out of 8 animals treated with HAX gels showed such adhesions, and those occurred in locations that were not covered by the hydrogel. We also studied means by which gel degradation time can be modulated by varying the precursor concentration and molecular weight.
Asunto(s)
Vendas Hidrocoloidales , Enfermedades del Ciego/prevención & control , Ácido Hialurónico/uso terapéutico , Enfermedades Peritoneales/prevención & control , Complicaciones Posoperatorias/prevención & control , Abdomen/patología , Abdomen/cirugía , Animales , Enfermedades del Ciego/patología , Supervivencia Celular , Reactivos de Enlaces Cruzados/química , Epitelio , Femenino , Humanos , Ácido Hialurónico/química , Enfermedades Peritoneales/patología , Complicaciones Posoperatorias/patología , Conejos , Adherencias Tisulares/patología , Adherencias Tisulares/prevención & control , Resultado del TratamientoRESUMEN
To improve the appeal of frozen baked foods upon heating, we have encapsulated flavor oil in complex coacervate microcapsules using gelatin and gum Arabic. Variation of polyion concentrations and homogenization rate affected particle morphology, size distribution, and oil release upon heating. Release of the oil from formulations was determined by a simple spectroscopic method based on separation of oil labeled with a lipophilic dye from unaffected particles. When heated to 100 degrees C or higher, univesicular microcapsules (prepared with a lower homogenization rate) released almost all of the encapsulated oil, while multivesicular microcapsules (produced by high homogenization rates) resulted had lesser degrees of release. The oil remained encapsulated during 4 weeks of storage at 4 and -20 degrees C (freezing and thawing) but was released by exposure to 100 mM NaCl at room temperature. When particles were cooled after releasing their oil content, the oil was re-encapsulated.
Asunto(s)
Aromatizantes/química , Calor , Cápsulas , Estabilidad de Medicamentos , Conservación de Alimentos , Congelación , Cromatografía de Gases y Espectrometría de Masas , Gelatina , Goma Arábiga , Aceites de Plantas/análisis , Aceites de Plantas/químicaRESUMEN
Soft tissue fillers are needed for restoration of a defect or augmentation of existing tissues. Autografts and lipotransfer have been under study for soft tissue reconstruction but yield inconsistent results, often with considerable resorption of the grafted tissue. A minimally invasive procedure would reduce scarring and recovery time as well as allow the implant and/or grafted tissue to be placed closer to existing vasculature. Here, the feasibility of an injectable silk foam for soft tissue regeneration is demonstrated. Adipose-derived stem cells survive and migrate through the foam over a 10-d period in vitro. The silk foams are also successfully injected into the subcutaneous space in a rat and over a 3-month period integrating with the surrounding native tissue. The injected foams are palpable and soft to the touch through the skin and returning to their original dimensions after pressure is applied and then released. The foams readily absorb lipoaspirate making the foams useful as a scaffold or template for existing soft tissue filler technologies, useful either as a biomaterial alone or in combination with the lipoaspirate.
Asunto(s)
Tejido Adiposo/citología , Inyecciones/métodos , Seda/administración & dosificación , Seda/química , Tejido Adiposo/fisiología , Animales , Materiales Biocompatibles , Movimiento Celular , Diseño de Equipo , Femenino , Humanos , Inyecciones/instrumentación , Ensayo de Materiales , Ratas Sprague-Dawley , Regeneración , Seda/farmacología , Andamios del TejidoRESUMEN
Cells change their shape and mechanics dramatically during development and tissue healing in response to morphogens, cell-cell contact, adhesion to extracellular matrix, and more. Several regulatory links have been described between cell shape, cytoskeletal tension, matrix adhesiveness and stiffness, and recent studies have begun to uncover how these mechanotransduction pathways can impact transcriptional signaling and cell fate decision. The integrated mechanisms linking cell forces, form and fate are likely critical for driving normal morphogenesis, tissue development, and healing. Dysregulation of these mechanisms may also tip the scale from normal to diseased states. Here, we highlight mechanisms that alter cell shape and mechanics, and the pathways affected by these changes.
Asunto(s)
Células Madre/citología , Animales , Diferenciación Celular , Forma de la Célula , Citoesqueleto/metabolismo , Matriz Extracelular/metabolismo , Humanos , Mecanotransducción Celular , Morfogénesis , Transducción de Señal , Células Madre/metabolismoRESUMEN
The effectiveness of rheological blends of high molecular weight hyaluronic acid (HA) and low molecular weight hydroxypropyl methylcellulose (HPMC) in the prevention of peritoneal adhesions post-surgery is demonstrated. The physical mixture of the two carbohydrates increased the dwell time in the peritoneum while significantly improving the injectability of the polymer compared with HA alone. HA-HPMC treatment decreased the total adhesion area by â¼ 70% relative to a saline control or no treatment in a repeated cecal injury model in the rabbit. No significant cytotoxicity and minimal inflammation were associated with the blend. Furthermore, no chemical or physical processing was required prior to their use beyond simple mixing.
Asunto(s)
Ácido Hialurónico/farmacología , Derivados de la Hipromelosa/farmacología , Peritoneo/patología , Reología , Adherencias Tisulares/prevención & control , Animales , Muerte Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Modelos Animales de Enfermedad , Humanos , Ácido Hialurónico/administración & dosificación , Ácido Hialurónico/toxicidad , Derivados de la Hipromelosa/administración & dosificación , Derivados de la Hipromelosa/toxicidad , Inyecciones Intraperitoneales , Masculino , Ratones , Peritoneo/efectos de los fármacos , ConejosRESUMEN
Silk protein-biomaterial wound dressings with epidermal growth factor (EGF) and silver sulfadiazine were studied with a cutaneous excisional mouse wound model. Three different material designs and two different drug incorporation techniques were studied to compare wound healing responses. Material formats included silk films, lamellar porous silk films and electrospun silk nanofibers, each studied with the silk matrix alone and with drug loading or drug coatings on the silk matrices. Changes in wound size and histological assessments of wound tissues showed that the functionalized silk biomaterial wound dressings increased wound healing rate, including reepithelialization, dermis proliferation, collagen synthesis and reduced scar formation, when compared to air-permeable Tegaderm tape (3M) (- control) and a commercial wound dressing, Tegaderm Hydrocolloid dressing (3M) (+ control). All silk biomaterials were effective for wound healing, while the lamellar porous films and electrospun nanofibers and the incorporation of EGF/silver sulfadiazine, via drug loading or coating, provided the most rapid wound healing responses. This systematic approach to evaluating functionalized silk biomaterial wound dressings demonstrates a useful strategy to select formulations for further study towards new treatment options for chronic wounds.
Asunto(s)
Vendas Hidrocoloidales , Seda/química , Seda/uso terapéutico , Piel/lesiones , Cicatrización de Heridas/efectos de los fármacos , Cicatrización de Heridas/fisiología , Heridas Penetrantes/fisiopatología , Heridas Penetrantes/terapia , Animales , Femenino , Ratones , Ratones Endogámicos C57BL , Piel/efectos de los fármacos , Piel/patología , Resultado del Tratamiento , Heridas Penetrantes/patologíaRESUMEN
The need for physiologically relevant sustainable human adipose tissue models is crucial for understanding tissue development, disease progression, in vitro drug development and soft tissue regeneration. The coculture of adipocytes differentiated from human adipose-derived stem cells, with endothelial cells, on porous silk protein matrices for at least 6 months is reported, while maintaining adipose-like outcomes. Cultures were assessed for structure and morphology (Oil Red O content and CD31 expression), metabolic functions (leptin, glycerol production, gene expression for GLUT4, and PPARγ) and cell replication (DNA content). The cocultures maintained size and shape over this extended period in static cultures, while increasing in diameter by 12.5% in spinner flask culture. Spinner flask cultures yielded improved adipose tissue outcomes overall, based on structure and function, when compared to the static cultures. This work establishes a tissue model system that can be applied to the development of chronic metabolic dysfunction systems associated with human adipose tissue, such as obesity and diabetes, due to the long term sustainable functions demonstrated here.
Asunto(s)
Tejido Adiposo/fisiología , Modelos Biológicos , Ingeniería de Tejidos/métodos , Adipogénesis/genética , Técnicas de Cultivo de Célula , ADN/metabolismo , Células Endoteliales/citología , Regulación de la Expresión Génica , Glicerol/metabolismo , Humanos , Leptina/metabolismo , Solubilidad , Andamios del Tejido/químicaRESUMEN
The efficacy and economy of most in vitro human models used in research is limited by the lack of a physiologically-relevant three-dimensional perfused environment and the inability to noninvasively quantify the structural and biochemical characteristics of the tissue. The goal of this project was to develop a perfusion bioreactor system compatible with two-photon imaging to noninvasively assess tissue engineered human adipose tissue structure and function in vitro. Three-dimensional (3D) vascularized human adipose tissues were engineered in vitro, before being introduced to a perfusion environment and tracked over time by automated quantification of endogenous markers of metabolism using two-photon excited fluorescence (TPEF). Depth-resolved image stacks were analyzed for redox ratio metabolic profiling and compared to prior analyses performed on 3D engineered adipose tissue in static culture. Traditional assessments with H&E staining were used to qualitatively measure extracellular matrix generation and cell density with respect to location within the tissue. The distribution of cells within the tissue and average cellular redox ratios were different between static and perfusion cultures, while the trends of decreased redox ratio and increased cellular proliferation with time in both static and perfusion cultures were similar. These results establish a basis for noninvasive optical tracking of tissue structure and function in vitro, which can be applied to future studies to assess tissue development or drug toxicity screening and disease progression.
Asunto(s)
Tejido Adiposo/citología , Reactores Biológicos , Metabolismo Energético/fisiología , Células Endoteliales de la Vena Umbilical Humana/citología , Imagenología Tridimensional , Ingeniería de Tejidos , Tejido Adiposo/metabolismo , Células Cultivadas , Matriz Extracelular/metabolismo , Células Endoteliales de la Vena Umbilical Humana/metabolismo , Humanos , PerfusiónRESUMEN
Current approaches to soft tissue regeneration include the use of fat grafts, natural or synthetic biomaterials as filler materials. Fat grafts and natural biomaterials resorb too quickly to maintain tissue regeneration, while synthetic materials do not degrade or regenerate tissue. Here, we present a simple approach to volume stable filling of soft tissue defects. In this study, we combined lipoaspirate with a silk protein matrix in a subcutaneous rat model. Silk biomaterials can be tailored to fit a variety of needs, and here were processed silk biomaterials into a porous sponge format to allow for tissue ingrowth while remaining mechanically robust. Over an 18 month period, the lipoaspirate seeded silk protein matrix regenerated subcutaneous adipose tissue while maintaining the original implanted volume. A silk protein matrix alone was not sufficient to regenerate adipose tissue, but yielded a fibrous tissue, although implanted volume was maintained. This work presents a significant improvement to the standard approaches to filling soft tissue defects by matching biomaterial degradation and tissue regeneration profiles.
Asunto(s)
Adipocitos/citología , Seda , Andamios del Tejido , Animales , Materiales Biocompatibles , Células Cultivadas , Humanos , Masculino , Ratones , Ratones Desnudos , Microscopía Electrónica de RastreoRESUMEN
Current approaches to skin equivalents often only include the epidermis and dermis. Here, a full-thickness skin equivalent is described including epidermis, dermis, and hypodermis, that could serve as an in vitro model for studying skin biology or as a platform for consumer product testing. The construct is easy to handle and is maintained for >14 d while expressing physiological morphologies of the epidermis and dermis, seen by keratin 10, collagens I and IV expression. The skin equivalent produces glycerol and leptin, markers of adipose metabolism. This work serves as a foundation for understanding a few necessary factors needed to develop a stable, functional model of full-thickness skin.